Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021

Upgrades

According to BMO Capital, the prior rating for Nuvei Corp NVEI was changed from Market Perform to Outperform.

BMO Capital upgraded the previous rating for Nuvei Corp NVEI from Market Perform to Outperform.

For Cadence Bank CADE, Janney Montgomery Scott upgraded the previous rating of Neutral to Buy. Cadence Bank earned $0.67 in the third quarter, compared to $0.40 in the year-ago quarter. At the moment, the stock has a 52-week-high of $32.12 and a 52-week-low of $14.47. Cadence Bank closed at $29.39 at the end of the last trading period.

According to Raymond James, the prior rating for Boyd Gaming Corp BYD was changed from Outperform to Strong Buy. For the third quarter, Boyd Gaming had an EPS of $1.30, compared to year-ago quarter EPS of $0.38. The current stock performance of Boyd Gaming shows a 52-week-high of $71.00 and a 52-week-low of $40.44. Moreover, at the end of the last trading period, the closing price was at $64.48.

Wells Fargo upgraded the previous rating for LGI Homes Inc LGIH from Underweight to Equal-Weight. In the third quarter, LGI Homes showed an EPS of $4.05, compared to $2.45 from the year-ago quarter. The current stock performance of LGI Homes shows a 52-week-high of $188.00 and a 52-week-low of $95.54. Moreover, at the end of the last trading period, the closing price was at $155.99.

For Twilio Inc TWLO, Barclays upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Twilio showed an EPS of $0.01, compared to $0.04 from the year-ago quarter. At the moment, the stock has a 52-week-high of $457.30 and a 52-week-low of $235.00. Twilio closed at $274.81 at the end of the last trading period.

Stifel upgraded the previous rating for JFrog Ltd FROG from Hold to Buy. JFrog earned $0.01 in the third quarter, compared to $0.05 in the year-ago quarter. At the moment, the stock has a 52-week-high of $72.28 and a 52-week-low of $27.65. JFrog closed at $32.37 at the end of the last trading period.

Oppenheimer upgraded the previous rating for Sarepta Therapeutics Inc SRPT from Perform to Outperform. For the third quarter, Sarepta Therapeutics had an EPS of $0.19, compared to year-ago quarter EPS of $1.42. The stock has a 52-week-high of $181.83 and a 52-week-low of $65.30. At the end of the last trading period, Sarepta Therapeutics closed at $86.02.

For Engagesmart Inc ESMT, Citigroup upgraded the previous rating of Neutral to Buy. In the third quarter, Engagesmart showed an EPS of $0.06, compared to $0.00 from the year-ago quarter.

Credit Suisse upgraded the previous rating for CVR Energy Inc CVI from Underperform to Neutral. CVR Energy earned $0.24 in the third quarter, compared to $0.57 in the year-ago quarter. At the moment, the stock has a 52-week-high of $27.02 and a 52-week-low of $11.22. CVR Energy closed at $16.50 at the end of the last trading period.

For UiPath Inc PATH, Berenberg upgraded the previous rating of Hold to Buy. UiPath earned $0.00 in the third quarter, compared to $0.41 in the year-ago quarter. The current stock performance of UiPath shows a 52-week-high of $90.00 and a 52-week-low of $42.02. Moreover, at the end of the last trading period, the closing price was at $47.71.

Wolfe Research upgraded the previous rating for Linde PLC LIN from Peer Perform to Outperform. In the third quarter, Linde showed an EPS of $2.73, compared to $2.15 from the year-ago quarter. At the moment, the stock has a 52-week-high of $340.16 and a 52-week-low of $240.80. Linde closed at $333.19 at the end of the last trading period.

Needham upgraded the previous rating for Inogen Inc INGN from Hold to Buy. In the third quarter, Inogen showed an EPS of $0.53, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $82.35 and a 52-week-low of $29.28. At the end of the last trading period, Inogen closed at $33.08.

For Instructure Holdings Inc INST, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. For the third quarter, Instructure Holdings had an EPS of $0.24, compared to year-ago quarter EPS of $0.13.

Morgan Stanley upgraded the previous rating for United Rentals Inc URI from Underweight to Equal-Weight. In the third quarter, United Rentals showed an EPS of $6.58, compared to $5.40 from the year-ago quarter. The current stock performance of United Rentals shows a 52-week-high of $414.99 and a 52-week-low of $217.39. Moreover, at the end of the last trading period, the closing price was at $356.96.

Barclays upgraded the previous rating for CRH PLC CRH from Underweight to Equal-Weight. The current stock performance of CRH shows a 52-week-high of $53.99 and a 52-week-low of $39.10. Moreover, at the end of the last trading period, the closing price was at $50.94.

Atlantic Equities upgraded the previous rating for Yum Brands Inc YUM from Neutral to Overweight. For the third quarter, Yum Brands had an EPS of $1.22, compared to year-ago quarter EPS of $1.01. At the moment, the stock has a 52-week-high of $135.77 and a 52-week-low of $101.18. Yum Brands closed at $131.74 at the end of the last trading period.

According to JP Morgan, the prior rating for Brookfield Renewable Partners LP BEP was changed from Neutral to Overweight. Brookfield Renewable earned $0.21 in the third quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $88.41 and a 52-week-low of $33.56. At the end of the last trading period, Brookfield Renewable closed at $34.38.

According to JP Morgan, the prior rating for Brookfield Renewable Corp BEPC was changed from Neutral to Overweight. At the moment, the stock has a 52-week-high of $107.83 and a 52-week-low of $34.13. Brookfield Renewable closed at $34.90 at the end of the last trading period.

For Occidental Petroleum Corp OXY, JP Morgan upgraded the previous rating of Underweight to Neutral. Occidental Petroleum earned $0.87 in the third quarter, compared to $0.84 in the year-ago quarter. The current stock performance of Occidental Petroleum shows a 52-week-high of $35.75 and a 52-week-low of $16.88. Moreover, at the end of the last trading period, the closing price was at $30.77.

Morgan Stanley upgraded the previous rating for Rio Tinto PLC RIO from Equal-Weight to Overweight. The current stock performance of Rio Tinto shows a 52-week-high of $95.97 and a 52-week-low of $59.58. Moreover, at the end of the last trading period, the closing price was at $63.88.

JP Morgan upgraded the previous rating for Phillips 66 PSX from Neutral to Overweight. For the third quarter, Phillips 66 had an EPS of $3.18, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $94.34 and a 52-week-low of $63.19. At the end of the last trading period, Phillips 66 closed at $71.85.

See all analyst ratings upgrades.

Downgrades

According to Goldman Sachs, the prior rating for Reata Pharmaceuticals Inc RETA was changed from Buy to Neutral. Reata Pharmaceuticals earned $1.27 in the third quarter, compared to $1.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $153.41 and a 52-week-low of $32.00. Reata Pharmaceuticals closed at $54.42 at the end of the last trading period.

According to RBC Capital, the prior rating for Diageo PLC DEO was changed from Sector Perform to Underperform. At the moment, the stock has a 52-week-high of $213.12 and a 52-week-low of $153.67. Diageo closed at $211.93 at the end of the last trading period.

According to Jefferies, the prior rating for Southwest Airlines Co LUV was changed from Buy to Hold. In the third quarter, Southwest Airlines showed an EPS of $0.23, compared to $1.99 from the year-ago quarter. The stock has a 52-week-high of $64.75 and a 52-week-low of $42.39. At the end of the last trading period, Southwest Airlines closed at $45.27.

For Snap One Holdings Corp SNPO, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. In the third quarter, Snap One Holdings showed an EPS of $0.24, compared to $0.02 from the year-ago quarter.

Morgan Stanley downgraded the previous rating for Liberty SiriusXM Group LSXMA from Overweight to Equal-Weight. The current stock performance of Liberty SiriusXM Gr shows a 52-week-high of $56.26 and a 52-week-low of $39.40. Moreover, at the end of the last trading period, the closing price was at $48.46.

SVB Leerink downgraded the previous rating for Reata Pharmaceuticals Inc RETA from Outperform to Market Perform. For the third quarter, Reata Pharmaceuticals had an EPS of $1.27, compared to year-ago quarter EPS of $1.31. The current stock performance of Reata Pharmaceuticals shows a 52-week-high of $153.41 and a 52-week-low of $32.00. Moreover, at the end of the last trading period, the closing price was at $54.42.

For Air Products & Chemicals Inc APD, Wolfe Research downgraded the previous rating of Outperform to Peer Perform. In the fourth quarter, Air Products & Chemicals showed an EPS of $2.51, compared to $2.19 from the year-ago quarter. The current stock performance of Air Products & Chemicals shows a 52-week-high of $316.39 and a 52-week-low of $245.75. Moreover, at the end of the last trading period, the closing price was at $295.67.

According to Morgan Stanley, the prior rating for Charter Communications Inc CHTR was changed from Overweight to Equal-Weight. For the third quarter, Charter Communications had an EPS of $6.50, compared to year-ago quarter EPS of $3.90. At the moment, the stock has a 52-week-high of $825.62 and a 52-week-low of $585.45. Charter Communications closed at $642.07 at the end of the last trading period.

According to Morgan Stanley, the prior rating for Allison Transmission Holdings Inc ALSN was changed from Equal-Weight to Underweight. For the third quarter, Allison Transmission had an EPS of $0.89, compared to year-ago quarter EPS of $0.68. The stock has a 52-week-high of $46.40 and a 52-week-low of $32.55. At the end of the last trading period, Allison Transmission closed at $36.12.

For Reata Pharmaceuticals Inc RETA, Baird downgraded the previous rating of Outperform to Neutral. For the third quarter, Reata Pharmaceuticals had an EPS of $1.27, compared to year-ago quarter EPS of $1.31. The stock has a 52-week-high of $153.41 and a 52-week-low of $32.00. At the end of the last trading period, Reata Pharmaceuticals closed at $54.42.

For Zimmer Biomet Holdings Inc ZBH, Needham downgraded the previous rating of Strong Buy to Buy. Zimmer Biomet Holdings earned $1.81 in the third quarter, compared to $1.81 in the year-ago quarter. At the moment, the stock has a 52-week-high of $180.36 and a 52-week-low of $119.55. Zimmer Biomet Holdings closed at $128.96 at the end of the last trading period.

JP Morgan downgraded the previous rating for Canadian Natural Resources Ltd CNQ from Overweight to Neutral. Canadian Natural Res earned $1.41 in the third quarter, compared to $0.08 in the year-ago quarter. The current stock performance of Canadian Natural Res shows a 52-week-high of $44.33 and a 52-week-low of $22.40. Moreover, at the end of the last trading period, the closing price was at $43.07.

According to JP Morgan, the prior rating for Altice USA Inc ATUS was changed from Overweight to Neutral. In the third quarter, Altice USA showed an EPS of $0.58, compared to $0.32 from the year-ago quarter. The current stock performance of Altice USA shows a 52-week-high of $38.30 and a 52-week-low of $15.47. Moreover, at the end of the last trading period, the closing price was at $15.86.

According to JP Morgan, the prior rating for Enviva Partners LP EVA was changed from Overweight to Neutral. Enviva Partners earned $0.63 in the third quarter, compared to $0.28 in the year-ago quarter. The current stock performance of Enviva Partners shows a 52-week-high of $73.33 and a 52-week-low of $44.01. Moreover, at the end of the last trading period, the closing price was at $72.95.

JP Morgan downgraded the previous rating for SunPower Corp SPWR from Neutral to Underweight. SunPower earned $0.06 in the third quarter, compared to $0.04 in the year-ago quarter. At the moment, the stock has a 52-week-high of $57.52 and a 52-week-low of $19.75. SunPower closed at $24.94 at the end of the last trading period.

According to RBC Capital, the prior rating for Cincinnati Financial Corp CINF was changed from Outperform to Sector Perform. In the third quarter, Cincinnati Financial showed an EPS of $1.28, compared to $0.39 from the year-ago quarter. The current stock performance of Cincinnati Financial shows a 52-week-high of $127.25 and a 52-week-low of $78.56. Moreover, at the end of the last trading period, the closing price was at $117.21.

According to RBC Capital, the prior rating for Marsh & McLennan Companies Inc MMC was changed from Outperform to Sector Perform. In the third quarter, Marsh & McLennan showed an EPS of $1.08, compared to $0.82 from the year-ago quarter. At the moment, the stock has a 52-week-high of $174.90 and a 52-week-low of $106.95. Marsh & McLennan closed at $172.91 at the end of the last trading period.

According to JP Morgan, the prior rating for CVR Energy Inc CVI was changed from Neutral to Underweight. In the third quarter, CVR Energy showed an EPS of $0.24, compared to $0.57 from the year-ago quarter. The current stock performance of CVR Energy shows a 52-week-high of $27.02 and a 52-week-low of $11.22. Moreover, at the end of the last trading period, the closing price was at $16.50.

According to Chardan Capital, the prior rating for Dicerna Pharmaceuticals Inc DRNA was changed from Buy to Neutral. Dicerna Pharmaceuticals earned $0.22 in the third quarter, compared to $0.29 in the year-ago quarter. The current stock performance of Dicerna Pharmaceuticals shows a 52-week-high of $40.14 and a 52-week-low of $19.06. Moreover, at the end of the last trading period, the closing price was at $38.00.

According to Wells Fargo, the prior rating for Allstate Corp ALL was changed from Equal-Weight to Underweight. Allstate earned $0.73 in the third quarter, compared to $2.94 in the year-ago quarter. At the moment, the stock has a 52-week-high of $140.00 and a 52-week-low of $102.44. Allstate closed at $109.02 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

With a Buy rating, EF Hutton initiated coverage on Trxade Health Inc MEDS. The price target seems to have been set at $4.50 for Trxade Health. In the third quarter, Trxade Health showed an EPS of $0.16, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $10.82 and a 52-week-low of $2.61. Trxade Health closed at $3.06 at the end of the last trading period.

With a Buy rating, Alliance Global Partners initiated coverage on XORTX Therapeutics Inc XRTX. The price target seems to have been set at $11.00 for XORTX Therapeutics. XORTX Therapeutics earned $0.03 in the fourth quarter, compared to $0.24 in the year-ago quarter.

Truist Securities initiated coverage on WR Berkley Corp WRB with a Buy rating. The price target for WR Berkley is set to $105.00. For the third quarter, WR Berkley had an EPS of $1.32, compared to year-ago quarter EPS of $0.65. The current stock performance of WR Berkley shows a 52-week-high of $84.93 and a 52-week-low of $61.49. Moreover, at the end of the last trading period, the closing price was at $79.90.

Wells Fargo initiated coverage on AbbVie Inc ABBV with an Overweight rating. The price target for AbbVie is set to $165.00. For the third quarter, AbbVie had an EPS of $3.33, compared to year-ago quarter EPS of $2.83. The current stock performance of AbbVie shows a 52-week-high of $122.45 and a 52-week-low of $101.55. Moreover, at the end of the last trading period, the closing price was at $121.87.

Wells Fargo initiated coverage on Regeneron Pharmaceuticals Inc REGN with an Overweight rating. The price target for Regeneron Pharmaceuticals is set to $750.00. Regeneron Pharmaceuticals earned $15.37 in the third quarter, compared to $8.36 in the year-ago quarter. The current stock performance of Regeneron Pharmaceuticals shows a 52-week-high of $686.62 and a 52-week-low of $441.00. Moreover, at the end of the last trading period, the closing price was at $654.04.

Wells Fargo initiated coverage on Vertex Pharmaceuticals Inc VRTX with an Overweight rating. The price target for Vertex Pharmaceuticals is set to $270.00. In the third quarter, Vertex Pharmaceuticals showed an EPS of $3.56, compared to $2.64 from the year-ago quarter. The stock has a 52-week-high of $242.99 and a 52-week-low of $176.36. At the end of the last trading period, Vertex Pharmaceuticals closed at $206.61.

With an Overweight rating, Wells Fargo initiated coverage on Merck & Co Inc MRK. The price target seems to have been set at $90.00 for Merck & Co. For the third quarter, Merck & Co had an EPS of $1.75, compared to year-ago quarter EPS of $1.74. At the moment, the stock has a 52-week-high of $91.40 and a 52-week-low of $15.32. Merck & Co closed at $73.21 at the end of the last trading period.

Wells Fargo initiated coverage on Biogen Inc BIIB with a Equal-Weight rating. The price target for Biogen is set to $250.00. For the third quarter, Biogen had an EPS of $4.77, compared to year-ago quarter EPS of $8.84. The current stock performance of Biogen shows a 52-week-high of $468.55 and a 52-week-low of $221.72. Moreover, at the end of the last trading period, the closing price was at $234.72.

Wells Fargo initiated coverage on Pfizer Inc PFE with an Overweight rating. The price target for Pfizer is set to $60.00. Pfizer earned $1.34 in the third quarter, compared to $0.72 in the year-ago quarter. At the moment, the stock has a 52-week-high of $55.70 and a 52-week-low of $33.36. Pfizer closed at $51.40 at the end of the last trading period.

With a Equal-Weight rating, Wells Fargo initiated coverage on Bristol-Myers Squibb Co BMY. The price target seems to have been set at $58.00 for Bristol-Myers Squibb. In the third quarter, Bristol-Myers Squibb showed an EPS of $2.00, compared to $1.63 from the year-ago quarter. The current stock performance of Bristol-Myers Squibb shows a 52-week-high of $69.75 and a 52-week-low of $53.22. Moreover, at the end of the last trading period, the closing price was at $57.60.

Wells Fargo initiated coverage on Amgen Inc AMGN with a Equal-Weight rating. The price target for Amgen is set to $210.00. In the third quarter, Amgen showed an EPS of $4.67, compared to $4.37 from the year-ago quarter. The current stock performance of Amgen shows a 52-week-high of $276.69 and a 52-week-low of $198.64. Moreover, at the end of the last trading period, the closing price was at $213.53.

Wells Fargo initiated coverage on Gilead Sciences Inc GILD with a Equal-Weight rating. The price target for Gilead Sciences is set to $72.00. In the third quarter, Gilead Sciences showed an EPS of $2.65, compared to $2.11 from the year-ago quarter. The current stock performance of Gilead Sciences shows a 52-week-high of $73.34 and a 52-week-low of $56.56. Moreover, at the end of the last trading period, the closing price was at $69.71.

With a Equal-Weight rating, Wells Fargo initiated coverage on Eli Lilly and Co LLY. The price target seems to have been set at $270.00 for Eli Lilly. In the third quarter, Eli Lilly showed an EPS of $1.94, compared to $1.54 from the year-ago quarter. At the moment, the stock has a 52-week-high of $275.87 and a 52-week-low of $146.91. Eli Lilly closed at $244.32 at the end of the last trading period.

Maxim Group initiated coverage on Recruiter.Com Group Inc RCRT with a Buy rating. The price target for Recruiter.Com Group is set to $9.00. The current stock performance of Recruiter.Com Group shows a 52-week-high of $5.86 and a 52-week-low of $1.55. Moreover, at the end of the last trading period, the closing price was at $3.76.

Macquarie initiated coverage on Informatica Inc INFA with an Outperform rating. The price target for Informatica is set to $40.00. For the third quarter, Informatica had an EPS of $0.23, compared to year-ago quarter EPS of $0.16.

William Blair initiated coverage on Lindblad Expeditions Holdings Inc LIND with a Market Perform rating. In the third quarter, Lindblad Expeditions showed an EPS of $0.50, compared to $0.56 from the year-ago quarter. The stock has a 52-week-high of $21.91 and a 52-week-low of $11.31. At the end of the last trading period, Lindblad Expeditions closed at $16.35.

Susquehanna initiated coverage on Forward Air Corp FWRD with a Positive rating. The price target for Forward Air is set to $132.00. For the third quarter, Forward Air had an EPS of $1.14, compared to year-ago quarter EPS of $0.61. The stock has a 52-week-high of $112.55 and a 52-week-low of $70.93. At the end of the last trading period, Forward Air closed at $109.90.

Susquehanna initiated coverage on Old Dominion Freight Line Inc ODFL with a Neutral rating. The price target for Old Dominion Freight Line is set to $395.00. In the third quarter, Old Dominion Freight Line showed an EPS of $2.47, compared to $1.71 from the year-ago quarter. At the moment, the stock has a 52-week-high of $373.58 and a 52-week-low of $189.45. Old Dominion Freight Line closed at $356.81 at the end of the last trading period.

Susquehanna initiated coverage on Saia Inc SAIA with a Positive rating. The price target for Saia is set to $400.00. Saia earned $2.86 in the third quarter, compared to $1.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $365.50 and a 52-week-low of $171.16. Saia closed at $330.34 at the end of the last trading period.

With a Positive rating, Susquehanna initiated coverage on TFI International Inc TFII. The price target seems to have been set at $132.00 for TFI International. At the moment, the stock has a 52-week-high of $120.50 and a 52-week-low of $50.10. TFI International closed at $109.12 at the end of the last trading period.

With a Buy rating, Stifel initiated coverage on Janus International Group Inc JBI. The price target seems to have been set at $17.00 for Janus Intl Gr. For the third quarter, Janus Intl Gr had an EPS of $0.11, compared to year-ago quarter EPS of $0.35. The current stock performance of Janus Intl Gr shows a 52-week-high of $15.94 and a 52-week-low of $11.60. Moreover, at the end of the last trading period, the closing price was at $12.48.

With a Equal-Weight rating, Morgan Stanley initiated coverage on Upstart Holdings Inc UPST. The price target seems to have been set at $200.00 for Upstart Holdings. The stock has a 52-week-high of $401.49 and a 52-week-low of $22.61. At the end of the last trading period, Upstart Holdings closed at $194.37.

JP Morgan initiated coverage on RAPT Therapeutics Inc RAPT with an Overweight rating. The price target for RAPT Therapeutics is set to $61.00. RAPT Therapeutics earned $0.63 in the third quarter, compared to $0.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of $43.26 and a 52-week-low of $14.89. RAPT Therapeutics closed at $30.89 at the end of the last trading period.

With an Overweight rating, JP Morgan initiated coverage on EVgo Inc EVGO. The price target seems to have been set at $20.00 for EVgo. At the moment, the stock has a 52-week-high of $19.59 and a 52-week-low of $7.17. EVgo closed at $12.17 at the end of the last trading period.

Stifel initiated coverage on Apollo Endosurgery Inc APEN with a Buy rating. The price target for Apollo Endosurgery is set to $12.00. In the third quarter, Apollo Endosurgery showed an EPS of $0.23, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $10.39 and a 52-week-low of $3.23. At the end of the last trading period, Apollo Endosurgery closed at $8.59.

With a Buy rating, DZ Bank initiated coverage on Cloudflare Inc NET. The price target seems to have been set at $200.00 for Cloudflare. For the third quarter, Cloudflare had an EPS of $0.00, compared to year-ago quarter EPS of $0.02. At the moment, the stock has a 52-week-high of $221.64 and a 52-week-low of $60.96. Cloudflare closed at $160.44 at the end of the last trading period.

Needham initiated coverage on Bicycle Therapeutics PLC BCYC with a Buy rating. The price target for Bicycle Therapeutics is set to $85.00. In the third quarter, Bicycle Therapeutics showed an EPS of $0.59, compared to $0.52 from the year-ago quarter. The stock has a 52-week-high of $62.08 and a 52-week-low of $17.95. At the end of the last trading period, Bicycle Therapeutics closed at $56.00.

With an Overweight rating, JP Morgan initiated coverage on FuboTV Inc FUBO. The price target seems to have been set at $28.00 for FuboTV. For the third quarter, FuboTV had an EPS of $0.59, compared to year-ago quarter EPS of $1.65. The stock has a 52-week-high of $62.29 and a 52-week-low of $14.64. At the end of the last trading period, FuboTV closed at $19.77.

With an Outperform rating, Oppenheimer initiated coverage on Green Plains Inc GPRE. The price target seems to have been set at $46.00 for Green Plains. Green Plains earned $1.18 in the third quarter, compared to $1.05 in the year-ago quarter. The current stock performance of Green Plains shows a 52-week-high of $44.27 and a 52-week-low of $11.91. Moreover, at the end of the last trading period, the closing price was at $38.36.

Oppenheimer initiated coverage on Opiant Pharmaceuticals Inc OPNT with an Outperform rating. The price target for Opiant Pharmaceuticals is set to $42.00. Opiant Pharmaceuticals earned $0.56 in the third quarter, compared to $0.15 in the year-ago quarter. The stock has a 52-week-high of $32.77 and a 52-week-low of $7.86. At the end of the last trading period, Opiant Pharmaceuticals closed at $32.20.

Oppenheimer initiated coverage on Benson Hill Inc BHIL with an Outperform rating. The price target for Benson Hill is set to $9.00. For the third quarter, Benson Hill had an EPS of $0.19, compared to year-ago quarter EPS of $0.11.

See all analyst ratings initiations.